1. Fabrication of apigenin nanoparticles using antisolvent crystallization technology: A comparison of supercritical antisolvent, ultrasonic-assisted liquid antisolvent, and high-pressure homogenization technologies.
- Author
-
Yan, Tingxuan, Wang, Haili, Song, Xingfang, Yan, Tingyuan, Ding, Yuwen, Luo, Kang, Zhen, Juan, He, Gui, Nian, Libin, Wang, Shuangshou, and Wang, Zhixiang
- Subjects
- *
SALTING out (Chemistry) , *APIGENIN , *X-ray powder diffraction , *DIFFERENTIAL scanning calorimetry , *NANOPARTICLES - Abstract
[Display omitted] • Apigenin nanoparticles were prepared by antisolvent crystallization technology. • Antisolvent technology optimization models were obtained using RSM design. • The crystal form of apigenin transforms into an amorphous form after the SEDS process. • The bioactivity of apigenin was improved. Flavonoids have many positive pharmacological properties, such as antioxidant, antitumor, and anti-inflammatory activities. However, factors such as low water solubility and low dissolution rate limit their use. To overcome their poor solubility, carrier-free apigenin (API) microparticles and nanoparticles were prepared using three types of antisolvent precipitation technologies: supercritical antisolvent (SCF) technology, ultrasonic-assisted liquid antisolvent (UAL) technology, and high-pressure homogenization (HPH) technology. All three technologies can produce uniform tiny particles. However, the API particles obtained using these different techniques show subtle differences in terms of physical and chemical properties and biological activity. The preparation, characterization, and potential use of API microparticles and nanoparticles to improve in vitro release were studied. The resulting API particles were investigated and compared using Fourier-transform infrared spectroscopy, differential scanning calorimetry, X-ray powder diffraction, and scanning electron microscopy. We determined the optimum conditions for SCF, UAL, and HPH technologies to produce API microparticles and nanoparticles. The antioxidant and antitumor properties of the API particles were also investigated. The results demonstrated that the reduced particle size of the APIs prepared via SCF, UAL, and HPH technologies contributed to the enhanced dissolution rate, which in turn enhanced API bioactivity. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF